Clinical Trial Update: Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AC2993 for improvement of glucose control and safety in adults with Type 2 diabetes treated with metformin, sulfonylurea, or both; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AC2993 (AC2993)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED